Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration

Human Reproduction

Volumn 22, Issue 10, 2007, Pages 2623-2631

  Moore, A B ^a   Castro, L ^a   Yu, L ^a   Zheng, X ^a   Di, X ^a   Sifre, M I ^a   Kissling, G E ^a   Newbold, R R ^a   Bortner, C D ^a   Dixon, D ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Cell proliferation; Genistein; Uterine leiomyoma (UtLM) cells; Uterine smooth muscle cells (UtSMCs)

Indexed keywords

CASPASE 3; CYCLINE; GENISTEIN;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE S PHASE; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUOROMETRY; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MYOMETRIUM; SMOOTH MUSCLE FIBER; TUMOR CELL; UTERUS MYOMA;

EID: 34548784918     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem185     Document Type: Article

References (52)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein. A specific inhibitor of tyrosine-specific protein kinases. J. Biol Chem 1987; 262: 5592-5595.
2. Akiyama T, Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:362-370.
3. Andersen J, DyReyes VM, Barbieri RL, Coachman DM, Miksicek RJ. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. J. Soc Gynecol Investig 1995;2:542-551.
4. Baggott JE, Ha T, Vaughn WH, Juliana MM, Hardin JM, Grubbs CJ. Effect of miso (Japanese soybean paste) and NaCl on DMBA-induced rat mammary tumors. Nutr Cancer 1990;14:103-109.
5. Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005;20:81-84.
6. Barbarisi A, Petillo O, Di Lieto A, Melone MA, Margarucci S, Cannas M, Peluso G. 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: Evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol 2001;186:414-424.
7. Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 1995;22:181-187.
8. Barnes S, Sfakianos J, Coward L, Kirk K. Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol 1996;401:87-100.
9. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15:725-731.
10. Bouker KB, Hilakivi-Clarke L. Genistein: Does it prevent or promote breast cancer? Environ Health Perspect 2000;108:701-708.
11. Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM. Estrogen receptor gene expression in human uterine leiomyomata. J. Clin Endocrinol Metab 1995;80:1876-1881.
12. Buttram VC, Jr, Reiter RC. Uterine leiomyomata: Etiology, symptomatology, and management. Ferril Steril 1981;36 433-445.
13. Carney SA, Tahara H, Swartz CD, Risinger JI, He H, Moore AB, Haseman JK, Barrett JC, Dixon D. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: Molecular and phenotypic characteristics. Lab Invest 2002;82:719-728.
14. Chen X, Anderson JJ. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 2001;41:165-171.
15. Chen WF, Wong MS. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 2004;89:2351-2359.
16. Conover W. Practical Nonparametric Statistics. New York, NY: John Wiley & Sons, Inc., 1971.
17. Constantinou AI, Kamath N, Murley IS. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 1998;34 1927-1934.
18. Cramer SF, Patel A. The frequency of uterine leiomyomis. Am J Clin Pathol 1990;94:435-438.
19. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003;188:100-107.
20. Dees C, Foster JS, Ahamed S, Wimalasena J. Dietary estrogens stimulate huma breast cells to enter the Cell cycle. Environ Health Perspect 1997;105(Suppl 3):633-636.
21. deLemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001;35:1118-1121.
22. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjoblorn P, Norgren A, Lindblom B. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J. Clin Endocrinol Metab 1998;83:4092-4096.
23. Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M, Di Fronzo G. Genistein in the control of breast cancer cell growth: Insights into the mechanism of action in vitro. Cancer Lett 1998;130:143-152.
24. Haney AF. Clinical decision makin regarding leiomyomata: What we need in the next millemum. Environ Health Perspect 2000;108(Suppl 5):835-839
25. Hunter DS, Hodges LC, Vonier PM, Fuchs-Young R, Gottardis MM, Walker CL. Estrogen receptor activation via activation function 2 predicts agonism. of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 1999;59:3090-3099.
26. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr 2000;30 1695-1699.
27. Kawaguchi K, Fujii S, Konishi I, Okamura H, Mori T. Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids. Gynecol Oncol 1985;21:32-41.
28. King A, Young G. Characteristics and occurrence of phenolic phytochemicals. J Am Diet Assoc 1999;99: 213-218.
29. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
30. Lamartiniere CA, Zhang JX, Cotroneo MS. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 1998;68:1400S-1405S.
31. Le Bail JC, Varnat F, Nicolas JC, Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett 1998;130:209-216.
32. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando, S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001;60:595-602.
33. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB, Larsen AK. Inhibitory effects of the tyrosine kinase inhibitor genistein on-mammalian DNA topoisomerase II. Cancer Res 1489;49:5111-5117.
34. McLachlan JA, Newbold RF, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 1980;40:3988-3999.
35. Messina M. Brief historical overview of isoflavone research. In: Gilani GS, Anderson JJBJ (eds). Phytoestrogens and Health. AOCS Press, Champaign, Minois, 2002,1-31.
36. Murrill WB, Brown NM, Zhang JX, Manzolillo, PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996;17 1451-1457.
37. Neter J, Kutner M, Nachtsheim C, Wasserman W. Applied Linear Statistical Models, 4th edn. WCB McGraw-Hill, Boston, 1996.
38. Newbold RR, Banks EP, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001;61 4325-4328.
39. Newbold RR, Moore AB, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol 2002;30:611-616.
40. O'Donnell AJM, Macleod KG, Burns DJ, Smyth JF, Langdon SP. Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer 2005;12:851-866.
41. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988;157:193-189.
42. Ososki AL, Kennelly EJ. Phytoestrogens: A review of the present state of research. Phytother Res 2003;17:845-869.
43. Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 1994; 30A: 1675-1682.
44. Po LS, Wang TT, Chen ZY, Leung LK. Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. Br J Nutr 2002;88:463-469.
45. Snedecor GW, Cochran WG. Statistical Methods. Sixth. Ames, Iowa: The Iowa State University Press, 1976.
46. Soyatech Syndicated Report. Lafayette, CA: 2006. P.O. Box 84, Bar Harbor, ME, and Soyfoods Center Survey, P.O. Box 234.
47. Swartz CD, Afshari CA, Yi L, Hall KE, Dixon D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 2005;11:4441-4450.
48. Stewart EA. Uterine fibroids. Lancet 2001;357:293-298.
49. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997;272:17907-17911.
50. Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996;17 271-275.
51. Wegienka G, Baird DD, Hertz-Picciotto I, Harlow SD, Steege IF, Hill MC, Schectman JM, Hartmann KE. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecot 2003;101:431-437.
52. Wise LA, Palmer Jr, Rowlings K, Kaufman RH, Herbst AL, Noller KL Titus-Ernstroff, Troisi R, Hatch EE, Robboy SJ. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol 2005;105:167-173.